Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

HealthyHome Welcomes Dr. Vincent C. Giampapa to Scientific Advisory Board


News provided by

HealthyHome

Aug 14, 2024, 16:36 ET

Share this article

Share toX

Share this article

Share toX


HealthyHome announces a new strategic partnership with Dr. Vincent Giampapa, M.D., F.A.C.S., a leading expert in cellular health and an anti-aging pioneer.

SALT LAKE CITY, Aug. 14, 2024 /PRNewswire-PRWeb/ -- HealthyHome announces a new strategic partnership with Dr. Vincent Giampapa, M.D., F.A.C.S., a leading expert in cellular health and an anti-aging pioneer. This collaboration strengthens HealthyHome's dedication to product innovation, science-backed solutions, and holistic wellness for the entire family and home.

Dr. Vincent C. Giampapa, MD, is a world-renowned medical doctor, inventor, and surgeon specializing in anti-aging medicine. He is one of the first Board Certified anti-aging physicians in the world. He is a co-founder of the American Academy of Anti-Aging Medicine and the first president of the American Board of Anti- Aging Medicine.

"HealthyHome is honored to welcome Dr. Vincent Giampapa as the first member of our newly formed Scientific Advisory Board." said Steve Perkins, CEO of HealthyHome.

Post this

Dr. Giampapa is the founder of the Regenerative Medicine Institute (RMI), located in Costa Rica, and is a visiting scholar at the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School.

"HealthyHome is honored to welcome Dr. Vincent Giampapa as the first member of our newly formed Scientific Advisory Board. His extensive research in cellular health and breakthroughs in anti-aging science align perfectly with our mission to promote healthy living," said Steve Perkins, CEO of HealthyHome. "His stem cell experience and forward-thinking approach to healthy aging will be invaluable as we continue to develop products and services that enhance the well-being of our community."

Dr. Giampapa was nominated for a Nobel Prize in 2014 for his groundbreaking research into cellular restoration technology. He also received a Gusi Peace Prize for his work in stem cell reprogramming. He received an Edison Award for developing the first epigenetic nutritional supplement and an A4M Science & Technology Award for developing the BioMarker Matrix Profile-the first computer program to measure aging. He served as a Nasa consultant for the space shuttle robotic arm and has been awarded 24 patents from the United States Government for unique cell culture delivery techniques, stem cell reprogramming, new drug delivery systems, and surgical instrument designs.

Dr. Giampapa is the author of five books on health and longevity and the first medical textbook on Anti-Aging Medicine and Age Management. Based on 34 years of surgical experience and 25 years of research, Dr. Giampapa is passionate about extending healthy life spans with enhanced functions. He views the global aging dilemma as one of the critical challenges for humanity in the next decade. His research focuses on stem cells and our body's innate ability to regenerate and maintain a longer and healthier life span.

"I am thrilled to be part of HealthyHome's commitment to science, research, and innovation," said Giampapa. "Stem cells represent one of the most significant discoveries of our time. HealthyHome has not only harnessed the potential of stem cell innovation but has also delivered other cutting-edge products. I am honored to be a part of this movement and look forward to supporting its growth and education."

Dr. Giampapa's addition to the HealthyHome team marks a significant milestone as they lead the way in developing healthy aging solutions and holistic wellness for the entire family and home.

For more information, please contact: [email protected]

About HealthyHome

HealthyHome products began shipping to homes globally in February 2023. Although it has reached thousands of individuals and homes world-wide, it is still considered to be in its "pre-launch" phase, with an official launch planned for the fall of 2024.

Since its start in 2023, HealthyHome's rapid success has been a direct result of its visionary and experienced leadership who are laying the foundation for global growth, groundbreaking products for the entire family and home, and long-lasting financial stability.

Central to its health movement is its flagship product: StemActive – a premium stem cell activator. Stem cells represent one of the most significant discoveries of our time, possessing the extraordinary ability to differentiate into various cell types, including blood, bone, and muscle cells. Learn more here: healthyhome.com/stemactive/

  • Facebook: @HealthyHomeGlobal
  • Instagram: @HealthyHomeGlobal
  • LinkedIn: @HealthyHomeGlobal

Media Contact
Brooks, HealthyHome, 1 1-385-323-5377, [email protected], www.healthyhome.com

SOURCE HealthyHome

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.